PRELIMINARY RESULTS OF THE EARLY USE OF CORTICOSTEROIDS WITH AXICABTAGEN CILOLEUCEL (AXI-CEL) IN PATIENTS DIAGNOSED WITH RELAPSED/REFRACTORY LARGE B CELL LYMPHOMA (R/R LBCL)

被引：0

作者：

Max, Topp S. ^{[1
]}

Van Meerten, T. ^{[2
]}

Wermke, M.

Pieternella, Lugtenburg J. ^{[3
]}

Monique, Minnema C. ^{[4
]}

Kevin, Song W. ^{[5
]}

Thieblemont, C.

Jiang, Y. ^{[6
]}

Plaks, V ^{[7
]}

Kerber, A. ^{[8
]}

Kersten, M. J. ^{[8
]}

机构：

[1] Univ Klinikum Wurzburg, Med Klin & Poliklin 2, Wurzburg, Germany

[2] Univ Med Ctr Groningen, Groningen, Netherlands

[3] Univ Hosp Carl Gustav Carus, Dresden, Germany

[4] Erasmus MC, Lunenburg Lymphoma Phase 1 2 Consortium HOVON LLP, Rotterdam, Netherlands

[5] Univ Med Ctr Utrecht, Utrecht, Netherlands

[6] Univ British Columbia, Vancouver, BC, Canada

[7] Hop St Louis, Paris, France

[8] Kite, Santa Monica, CA USA

来源：

HAEMATOLOGICA | 2019年 / 104卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

CO-132

引用

页码：98 / 98

页数：1

共 50 条

[41] ZUMA-7: A phase 3 randomized trial of axicabtagene ciloleucel (Axi-Cel) versus standard-of-care (SOC) therapy in patients with relapsed/refractory diffuse large B cell lymphoma (R/R DLBCL).
Oluwole, Olalekan O.
Bishop, Michael Russell
Gisselbrecht, Christian
Gordon, Leo I.
Kersten, Marie Jose
Maloney, David G.
Schmitz, Norbert
Barrigon, Maria Dolores Caballero
Kuruvilla, John
Song, Kevin W.
Jacobson, Caron A.
Nastoupil, Loretta J.
Riedell, Peter
Jiang, Yizhou
Rossi, John M.
Lee, Lillian
Cheng, Paul C.
Locke, Frederick Lundry
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[42] Real-world outcomes of axicabtagene ciloleucel (Axi-cel) for the treatment of large B-cell lymphoma (LBCL) by race and ethnicity.
Locke, Frederick L.
Siddiqi, Tanya
Jacobson, Caron Alyce
Ghobadi, Armin
Ahmed, Sairah
Miklos, David Bernard
Perales, Miguel-Angel
Munoz, Javier
Logan, Brent
Hu, Zhen-Huan
Miao, Harry H.
Singh, Kanwarjit
Shah, Jina
Xu, Hairong
Pasquini, Marcelo C.
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[43] Real-world evidence of axicabtagene ciloleucel (Axi-cel) for the treatment of large B-cell lymphoma (LBCL) in the United States (US).
Jacobson, Caron A.
Locke, Frederick Lundry
Hu, Zhen-Huan
Siddiqi, Tanya
Ahmed, Sairah
Ghobadi, Armin
Miklos, David Bernard
Lin, Yi
Perales, Miguel-Angel
Lunning, Matthew Alexander
Herr, Megan
Hill, Brian T.
Ganguly, Siddhartha
Dong, Hua
Nikiforow, Sarah
Xie, Jing
Xu, Hairong
Hooper, Michele
Kawashima, Jun
Pasquini, Marcelo C.
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[44] Association of pretreatment (preTx) tumor characteristics and clinical outcomes following second-line (2L) axicabtagene ciloleucel (axi-cel) versus standard of care (SOC) in patients (pts) with relapsed/refractory (R/R) large B-cell lymphoma (LBCL).
Locke, Frederick L.
Chou, Justin
Vardhanabhuti, Saran
Perbost, Regis
Dreger, Peter
Hill, Brian T.
Lee, Catherine
Zinzani, Pier Luigi
Kroeger, Nicolaus
Lopez-Guillermo, Armando
Greinix, Hildegard
Zhang, Wangshu
Tiwari, Gayatri
To, Christina Ann
Cheng, Paul C.
Bot, Adrian
Shen, Rhine
Filosto, Simone
Galon, Jerome
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[45] Axicabtagene ciloleucel (axi-cel) in combination with rituximab (Rtx) for the treatment (Tx) of refractory large B-cell lymphoma (R-LBCL): Outcomes of the phase 2 ZUMA-14 study.
Strati, Paolo
Leslie, Lori Ann
Shiraz, Parveen
Budde, L. Elizabeth
Oluwole, Olalekan O.
Ulrickson, Matthew
Ramakrishnan, Aravind
Sun, Jennifer
Shen, Rhine
Kanska, Justyna
McCroskery, Peter
Dong, Jinghui
Schupp, Marco Andreas
Xu, Hairong
Patel, Krish
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[46] A Comparison of 2-Year Outcomes in ZUMA-1 (Axicabtagene Ciloleucel; Axi-Cel) and SCHOLAR-1 in Patients (Pts) with Refractory Large B Cell Lymphoma (LBCL)
Neelapu, Sattva S.
Locke, Frederick L.
Bartlett, Nancy L.
Lekakis, Lazaros J.
Reagan, Patrick
Miklos, David B.
Jacobson, Caron A.
Braunschweig, Ira
Oluwole, Olalekan
Siddiqi, Tanya
Lin, Yi
Crump, Michael
Kuruvilla, John
Van den Neste, Erin
Farooq, Umar
Navale, Lynn
DePuy, Venita
Kim, Jenny
Gisselbrecht, Christian
MOLECULAR THERAPY, 2020, 28 (04) : 575 - 576
[47] A Comparison of 2-Year Outcomes in ZUMA-1 (Axicabtagene Ciloleucel [Axi-Cel]) and SCHOLAR-1 in Patients (Pts) with Refractory Large B Cell Lymphoma (LBCL)
Neelapu, Sattva S.
Locke, Frederick L.
Bartlett, Nancy L.
Lekakis, Lazaros J.
Reagan, Patrick M.
Miklos, David B.
Jacobson, Caron A.
Braunschweig, Ira
Oluwole, Olalekan O.
Siddiqi, Tanya
Lin, Yi
Crump, Michael
Kuruvilla, John
Van Den Neste, Eric
Farooq, Umar
Navale, Lynn
DePuy, Venita
Kim, Jenny J.
Gisselbrecht, Christian
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S232 - S232
[48] Long-Term Survival and Gradual Recovery of B Cells in Patients with Refractory Large B Cell Lymphoma Treated with Axicabtagene Ciloleucel (Axi-Cel)
Jacobson, Caron
Locke, Frederick L.
Ghobadi, Armin
Miklos, David B.
Lekakis, Lazaros J.
Oluwole, Olalekan O.
Lin, Yi
Braunschweig, Ira
Hill, Brian T.
Timmerman, John M.
Deol, Abhinav
Reagan, Patrick M.
Stiff, Patrick J.
Flinn, Ian W.
Farooq, Umar
Goy, Andre H.
McSweeney, Peter A.
Munoz, Javier
Siddiqi, Tanya
Rossi, John M.
Bot, Adrian
Zheng, Lianqing
Vezan, Remus
Bashir, Zahid
Kim, Jenny J.
Chu, Rong
Neelapu, Sattva S.
BLOOD, 2020, 136
[49] Primary Analysis of Zuma-5: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory (R/R) Indolent Non-Hodgkin Lymphoma (iNHL)
Jacobson, Caron
Chavez, Julio C.
Sehgal, Alison R.
William, Basem M.
Munoz, Javier
Salles, Gilles
Munshi, Pashna N.
Casulo, Carla
Maloney, David
De Vos, Sven
Reshef, Ran
Leslie, Lori A.
Yakoub-Agha, Ibrahim
Oluwole, Olalekan O.
Fung, Henry C. H.
Rosenblatt, Joseph D.
Rossi, John M.
Goyal, Lovely
Plaks, Vicki
Yang, Yin
Lee, Jennifer
Godfrey, Wayne
Vezan, Remus
Avanzi, Mauro P.
Neelapu, Sattva S.
BLOOD, 2020, 136
[50] Matching-adjusted indirect comparison of axi-cel and liso-cel in relapsed or refractory large B-cell lymphoma
Oluwole, Olalekan O.
Chen, Jenny M. H.
Chan, Keith
Patel, Anik R.
Jansen, Jeroen P.
Keeping, Sam
Zheng, Yan
Snider, Julia T.
Locke, Frederick L.
LEUKEMIA & LYMPHOMA, 2022, 63 (13) : 3052 - 3062

← 1 2 3 4 5 →